Benefits of Venetoclax endure years after blood cancer clinical trial
A study which tracked the long-term outcomes of blood cancer patients involved in the MURANO…
Browsing: Leukaemia
An area of the brain where tumour cells shelter from chemotherapy in childhood leukaemia
The stroma of the choroid plexus is one of the locations within the central nervous…
Potential cause of immunotherapy-related neurotoxicity
New research has uncovered the previously unknown presence of CD19 — a B cell molecule…
Novel immune-oncology approach for potential cancer treatment
A research collaboration between Monash University and Lava Therapeutics details a novel immune-oncology approach for…
Whole genome sequencing recommended to improve treatment targeting for leukaemia patients
Researchers have identified a new gene mutation causing treatment resistance in acute lymphoblastic leukaemia. The…
FDA approves azacitidine tablets for acute myeloid leukaemia
On September 1, 2020, the Food and Drug Administration approved azacitidine tablets (ONUREG) for continued…
First drug-like compounds to inhibit elusive cancer-linked enzymes developed
A team of scientists from the University of Michigan Rogel Cancer Center, USA, has developed…
CircASXL1-1 regulates BAP1 deubiquitinase activity in leukaemia
Every year, 1.1 million new cases of blood cancers are diagnosed worldwide. Presently, chemotherapy remains…
Combination therapy improves survival outcomes for patients with acute myeloid leukaemia
A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over…
ASH releases new clinical practice guidelines on acute myeloid leukaemia in older adults
ASH have published new guidelines to help older adults with acute myeloid leukaemia (AML) and…